Sarepta Therapeutics (SRPT) Return on Sales (2012 - 2026)

Sarepta Therapeutics' Return on Sales history runs 13 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Sales rose 4.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.01% for Q1 2026 at Sarepta Therapeutics, up from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.02% in Q4 2022 to a low of 0.05% in Q1 2022.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.0% in 2023.
• The sharpest annual moves came in 2022 and 2026: Return on Sales slipped 4 bps in 2022, then increased 4 bps in 2026.
• A 5-year view of Return on Sales shows it stood at 0.02% in 2022, then tumbled by 67 bps to 0.01% in 2023, then plunged by 84 bps to 0.0% in 2024, then sank by 731 bps to 0.01% in 2025, then jumped by 229 bps to 0.01% in 2026.
• The last three Return on Sales figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.